In a previous paper, 1,2) a series of 2,3-disubstituted 1,4-naphthoquinones were synthesized and their antiplatelet, antiinflammatory, and antiallergic activities were evaluated. Among them, compounds 1-4 (Chart 1) showed potent inhibitory effect on neutrophil and mast cell degranulation. In particular, 2-chloro-3-methoxy-1,4-naphthoquinone (1) had impressive IC 50 values of 0.5 and 0.9 mM against neutrophil and mast cell degranulation, respectively. Encouraged by this preliminary result, in this investigation we explored further the chain length of compounds 1 and 3. During the screening for antiplatelet, antiinflammatory, and antiallergic activities, we found that some of the target compounds demonstrated improved and more potent activity in comparison with 1 and 3. Our findings are summarized in this report.
Chemistry
The target compounds, 2-alkoxy-3-chloro-1,4-naphthoquinones (5-9) and 2-alkoxy-1,4-naphthoquinones (10) (11) (12) (13) (14) , were synthesized as shown in Charts 2 and 3. The preparation of two typical compounds, 2-chloro-3-propoxy-1,4-naphthoquinone (5) and 2-propoxy-1,4-naphthoquinones (10) , is described to illustrate the general procedures. As shown in Chart 2, the starting 2,3-dichloro-1,4-naphthoquinone was treated with sodium propoxide in propanol to form 5. As illustrated in Chart 3, the starting 2-hydroxy-1,4-naphthoquinone was treated with propyl iodide in the presence of silver oxide to afford 10. Antiplatelet Activity 3, 4) As indicated in Table 1 , all of the synthesized compounds significantly inhibited arachidonic acid (AA)-, collagen-, and platelet-activating factor (PAF)-induced platelet aggregation. On the contrary, they did not inhibit thrombin-induced aggregation at concentractions up to 100 mg/ml (not shown in Table 1 ). In other words, these compounds showed similar patterns of preferential inhibition toward platelet aggregation to that of compound 1. Their inhibitory potency is greatest against AA-and collagen-induced platelet aggregation, whereas their potency is only moderate against PAF-induced aggregation, and the weakest toward thrombin-induced aggregation.
Among compounds 5-7, the inhibitory potency against AA-, collagen-, and PAF-induced platelet aggregation was found to increase with increasing 2-alkoxy chain length. Alternatively, the phenoxy group was introduced into the 2-position to obtain 9. Such modification resulted in greatly enhanced potency against AA-, collagen-, and PAF-induced platelet aggregation.
Replacing the 3-chloro groups of compounds 5-8 with hydrogens yielded compounds 10 and 12-14, with slightly lower potency against AA-and collagen-induced platelet aggregation. These results suggest that the presence of a chloro group at the 3-position of the tested compounds plays an effective role, as does the increase in the alkoxy chain length at 2-position. In general, the better inhibitory effect on the AAand collagen-induced response of this series of compounds implies the inhibition of prostaglandin production, although confirmation of this awaits further investigation.
Antiinflammatory Activity Effect on Neutrophil Degranulation 5, 6) : The inhibitory effects of compounds 5-14 on neutrophil degranulation were examined. As can be seen in Table 2 , the potency of compounds 5-8 were about 2-4- fold less potent than compound 1 in terms of their inhibitory effect on the neutrophil degranulation induced by formylMet-Leu-Phe (fMLP). The inhibitory potency was reduced markedly when a phenoxy group was placed at the 2-position (compound 9). On the other hand, the potency of compounds 10-13 was found to increase over compound 3 in proportion with the length of their 2-alkoxy chains.
Synthesis of 2-Alkoxy 1,4-Naphthoquinone Derivatives as Antiplatelet, Antiinflammatory, and Antiallergic Agents
Effect on Neutrophil Superoxide Formation 7, 8) :
The screening results in the neutrophil superoxide formation assay are shown in Table 3 . All tested compounds demonstrated significant inhibitory effect on neutrophil superoxide anion formation induced by fMLP. Among them, the 3-chloro analogues 5-9 were nearly equipotent in comparison with lead compound 1, while the 3-unsubstituent analogues 10-12 were more potent than their parent compound 3. Most importantly, both compounds 10 and 12, with IC 50 values of 0.6 mM, are 25 times more potent than the positive control (trifluoperazine).
Antiallergic Activity Effect on Mast Cell Degranulation 9, 10) : The inhibitory effects of compounds 5-14 on mast cell degranulation were examined. As shown in Table 4 , all 3-chloro analogues (5-9) exhibited almost the same in- Platelets were incubated with test compounds at 37°C for 1 min, then thrombin (0.1 unit/ml), arachidonic acid (AA, 100 mM), collagen (10 mg/ml), or platelet-activating factor (PAF, 2 ng/ml) was added to trigger the aggregation. Values are expressed as the concentration (mM) at which 50% inhibition of platelet aggregation occurred (IC 50 ). Aspirin was used as a positive control. a) The accuracy of IC 50 values are withinϮ10%. The neutrophil suspension was preincubated at 37°C with 0.5% DMSO or a test compound for 10 min in the presence of cytochalasin B (5 mg/ml). Forty-five minutes after the addition of fMLP (1 mM), b-glucuronidase and lysozyme levels in the supernatant were determined. Values are expressed as the concentration (mM) at which 50% inhibition of neutrophil degranulation occurred (IC 50 ). Trifluoperazine was used as a positive control. a) The accuracy of IC 50 values are withinϮ10%. The neutrophil suspension in the presence of tern cytochrome c was preincubated at 37°C with 0.5% DMSO or a test compound for 10 min in the presence of cytochalasin B (5 mg/ml). Fifteen minutes after the addition of fMLP (0.3 mM), the absorbance was determined at 550 nm. Values are expressed as the concentration (mM) at which 50% inhibition of neutrophil superoxide anion formation occurred (IC 50 ). Trifluoperazine was used as a positive control. ND, not determined. a) The accuracy of IC 50 values are withinϮ10%. The mast cell suspension was preincubated at 37°C with 0.5% DMSO or test compound for 3 min. Fifteen minutes after the addition of compound 48/80 (10 mg/ml), bglucuronidase and histamine levels in the supernatant were determined. Values are expressed as the concentration (mM) at which 50% inhibition of mast cell degranulation occurred (IC 50 ). Mepacrine was used as a positive control. a) The accuracy of IC 50 values are withinϮ10%.
hibitory effect as their parent compound 1 on mast cell degranulation induced by compound 48/80 (10 mg/ml). Meanwhile, regardless of the higher potency than their lead compound 3, the 3-unsubstituted compounds 10-12 were less potent than their 3-chloro counterparts 5 and 6. However, compounds 7 and 8 exhibited potency similar to that of their 3-unsubstituted counterparts 13 and 14. Experimental IR spectra were recorded on a Nicolet Impact 400 FT-IR spectrophotometer as KBr pellets. NMR spectra were obtained on a Bruker Avance DPX-200 FT-NMR. MS were measured with HP 5995 GC-MS and VG PLAT-FORM II GC-MS instruments. Elemental analyses of C, H, and N were carried out on a Perkin-Elmer 2400 Series II CHNS/O Analyzer and were accurate within Ϯ0.4% of theoretical values.
2-Alkoxy-3-chloro-1,4-naphthoquinones 5-9 Sodium alkoxide (20 mmol) was added to a suspension of 2,3-dichloro-1,4-naphthoquinone (20 mmol) in anhydrous THF (20 ml). The reaction mixture was stirred for 5 min at room temperature, then poured into ice water, and extracted with chloroform. After drying and removal of the solvent, chromatographic purification on silica gel afforded the desired naphthoquinones 5-9 (Table 5) .
2-Alkoxy-1,4-naphthoquinones 10-14 A mixture of 2-hydroxy-1,4-naphthoquinone (15 mmol), alkyl iodide (20 mmol), silver oxide (20 mmol), and chloroform (50 ml) was heated under reflux for 2 h. The cooled reaction mixture was filtered and the filtrate was evaporated to dryness. The residue was chromatographed on silica gel to give 10-14 (Table 5) .
